Morningside Group
Edit

Morningside Group

http://www.morningside.com
Last activity: 17.06.2025
Active
Invests in categories: HealthTechPlatformTechnologyAgriTechServiceFoodTechProductCareDataDesign
The Morningside group invests private-equity and venture capital in novel science and technology sectors and is committed to social responsibility.
Portfolio
50
Mentions
92
Investment Type: Venture Capital
Investment Stage: Seed; Series A; Series B

Portfolio 50

DateNameWebsiteTotal RaisedLocation
20.02.2025Cydar Medi...cydarmedical.com$3.95MUnited Kin...
20.02.2025Prospectiv...prospectiveresearch.com-United Sta...
20.02.2025Monumentmonument.co$89.21MUnited Kin...
06.04.2023Gaeastargaeastar.com$6.5MGermany, B...
08.02.2023Evonetixevonetix.com$66.6MUnited Kin...
11.05.2022SimpliFedsimplifed.com$10MUnited Sta...
17.04.2022HOMEE, Inc...homee.com$62.3MJapan, Usa
29.09.2021Semiossemios.com$175.45MCanada, Br...
08.07.2021Linus Heal...linus.health$55MUnited Sta...
21.03.2019Jitjatjojitjatjo.com$41MUnited Sta...
Show more

Mentions in press and media 92

DateTitleDescription
17.06.2025HOPPR Secures $31.5M Series A to Scale AI Infrastructure for Medical ImagingBacked by top-tier investors, HOPPR is scaling its secure platform for enabling developersand medical imaging partners to build, refine, and deploy AI applications. HOPPR, the company revolutionizing how AI imaging applications are built, v...
26.03.2025Capitala Group and Xealth: A Tale of Two Investments in GrowthIn the bustling world of finance and technology, two stories emerged recently, each a testament to the power of investment in driving growth. Capitala Group, a private markets investment firm, and Xealth, a digital health company, both secu...
26.03.2025Fleetio's Bold Move: A $450 Million Leap into Fleet Maintenance InnovationIn the fast-paced world of fleet management, change is the only constant. Fleetio, a Birmingham-based software powerhouse, has just made waves with a monumental $450 million Series D funding round. This isn’t just a cash infusion; it’s a st...
25.03.2025Fleetio Raises over $450M in Series D; Acquires Auto IntegrateFleetio, a Birmingham, AL-based provider of a fleet optimization software platform, raised over $450M in Series D funding. The round was led by Elephant and new investor Growth Equity at Goldman Sachs Alternatives. The company has also acqu...
25.03.2025Xealth Receives Investment from Morningside VenturesXealth, a Seattle, WA-based company that develops digital health enablement solutions for health systems, received an investment from Morningside Ventures. The amount of the deal was not disclosed. The company intends to use the funds to ex...
19.02.2025SimpliFed: $4 Million Raised For Building Maternal Care At Home PlatformVirtual maternal healthcare SimpliFed announced that it has raised a new $4 million in funding. This funding was led by Morningside and included new investors The Artemis Fund, Cultivation Capital, and American Heart Association Social Impa...
07.02.2025SimpliFed: A New Dawn in Virtual Maternal HealthcareIn the realm of maternal healthcare, a revolution is brewing. SimpliFed, a New York City-based company, has secured $4 million in funding to expand its virtual maternal healthcare platform. This investment, led by Morningside and supported ...
04.02.2025SimpliFed Raises $4M to Expand Virtual Maternal Healthcare PlatformWhat You Should Know: – SimpliFed, a provider of virtual maternal healthcare, today announced a $4M funding round led by Morningside. – The investment will support the company’s expansion from a point solution focused on baby feeding to a c...
10.01.2025Geneoscopy: $105 Million (Series C) Raised For Developing Advanced Gastrointestinal Diagnostic TestsGeneoscopy – a life sciences company focused on developing diagnostic tests for advancing gastrointestinal health – announced the closing of a Series C funding round raising $105 million. Bio-Rad Laboratories led the financing and was joine...
09.01.2025Geneoscopy's Bold Leap: $105M Series C Funding Fuels Gastrointestinal Diagnostics RevolutionIn the world of healthcare, innovation is the lifeblood. Geneoscopy, a St. Louis-based life sciences company, has just injected a hefty $105 million into its veins through a Series C funding round. This financial boost is not just a number;...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In